These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7890061)

  • 21. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of angiopoietin-1 and -2 in the endometrium of women with abnormal bleeding induced by an intra-uterine device.
    Qian HL; Wang HF; Yang ML
    J Int Med Res; 2010; 38(1):100-10. PubMed ID: 20233519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
    Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
    Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological study of the endometrium of 459 intrauterine contraceptive device (IUD) users.
    Katsura S; Satodade R
    Yokohama Med Bull; 1969 Oct; 20(5):137-44. PubMed ID: 5402647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased endometrial HOXA10 expression associated with use of the copper intrauterine device.
    Tetrault AM; Richman SM; Fei X; Taylor HS
    Fertil Steril; 2009 Dec; 92(6):1820-4. PubMed ID: 18930214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle.
    Zhou J; Dsupin BA; Giudice LC; Bondy CA
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1723-34. PubMed ID: 7527408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium.
    Pekonen F; Nyman T; Lähteenmäki P; Haukkamaa M; Rutanen EM
    J Clin Endocrinol Metab; 1992 Aug; 75(2):660-4. PubMed ID: 1379263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal and site-specific expression of transforming growth factor-beta4 in human endometrium.
    Tabibzadeh S; Lessey B; Satyaswaroop PG
    Mol Hum Reprod; 1998 Jun; 4(6):595-602. PubMed ID: 9665343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA metabolism of the normal and the copper treated human endometrium.
    Perez OH; Aznar R; Ballesteros LM; Mendez JD; Rosado A
    Contraception; 1976 Oct; 14(4):421-33. PubMed ID: 975827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine expression in human endometrium throughout the menstrual cycle.
    Tabibzadeh S; Sun XZ
    Hum Reprod; 1992 Oct; 7(9):1214-21. PubMed ID: 1479000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrastructural changes in human endometrium with copper and nonmedicated IUDs in utero.
    El-Badrawi HH; Hafez ES; Barnhart MI; Fayad M; Shafeek A
    Fertil Steril; 1981 Jul; 36(1):41-9. PubMed ID: 7250406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of long-term installation of intrauterine devices on intrauterine microenvironment].
    Dong BH; Hou GH; Zhang YZ; Fan J; Zhang P; Li L; Luo X
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):823-6. PubMed ID: 12895331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor-alpha messenger RNA variants that lack exon 5 or exon 7 are coexpressed with wild-type form in human endometrium during all phases of the menstrual cycle.
    Marshburn PB; Zhang J; Bahrani-Mostafavi Z; Mostafavi BZ; Marroum MC; Mougeot JL; Roshon MJ
    Am J Obstet Gynecol; 2004 Aug; 191(2):626-33; discussion 633-4. PubMed ID: 15343251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrial L-selectin ligand is downregulated in the mid-secretory phase during the menstrual cycle in women with adenomyosis.
    Lai TH; Chang FW; Lin JJ; Ling QD
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):507-516. PubMed ID: 30122569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the intrauterine contraceptive device on endometrial enzyme and carbohydrate histochemistry.
    Hester LL; Kellett WW; Spicer SS; Williamson HO; Pratt-Thomas HR
    Am J Obstet Gynecol; 1970 Apr; 106(8):1144-54. PubMed ID: 4314520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of intrauterine devices: biochemical changes.
    Johannisson E
    Contraception; 1987 Jul; 36(1):11-22. PubMed ID: 3311620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.